ロード中...
TAS2R38 is a novel modifier gene in patients with cystic fibrosis
The clinical manifestation of cystic fibrosis (CF) is heterogeneous also in patients with the same cystic fibrosis transmembrane regulator (CFTR) genotype and in affected sibling pairs. Other genes, inherited independently of CFTR, may modulate the clinical manifestation and complications of patient...
保存先:
| 出版年: | Sci Rep |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group UK
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7118092/ https://ncbi.nlm.nih.gov/pubmed/32242045 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-62747-9 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|